Title : Antitumor effect of vandetanib through EGFR inhibition in head and neck squamous cell carcinoma.

Pub. Date : 2012 Sep

PMID : 22307735






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Vandetanib is a small-molecule tyrosine kinase inhibitor (TKI) with dual specificity for EGFR and VEGFR. vandetanib kinase insert domain receptor Homo sapiens